Nivolumab in der Therapie des hepatozellulären Karzinoms
Crossref DOI link: https://doi.org/10.1007/s15004-018-6044-1
Published Online: 2018-04-14
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schultheiß, Michael
Text and Data Mining valid from 2018-04-01
Article History
First Online: 14 April 2018